Hepatitis B Therapy
RNA interference suppresses HBV replication in cell cultures and animal liver
Published in Hepatitis Weekly, July 28th, 2003
"Hepatitis B virus (HBV) infection substantially increases the risk of chronic liver disease and hepatocellular carcinoma in humans. RNA interference (RNAi) of virus-specific genes has emerged as a potential antiviral mechanism. Here we show that RNAi can be applied to inhibit production of HBV replicative intermediates in cell culture and in immunocompetent and immunodeficient mice transfected with an HBV plasmid," scientists in the United States report.
"Cotransfection with plasmids expressing short hairpin RNAs (shRNAs) homologous to HBV mRNAs induced an RNAi response....
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
Source: Hepatitis Weekly (2003-07-28)
More Articles from Hepatitis Weekly
- Hepatitis C Virus
HCV infection raises the risk for type 2 diabetes in predisposed individuals - Obstetrics
Lamivudine reduces hepatitis B virus vertical transmission risk - Environmental Health
Atomic bomb survivors may have trouble clearing hepatitis B virus infections - Occupational Medicine
Sexual transmission supercedes occupation for dental worker GBV-C infections - Virology
LightCycler PCR assay offers a rapid way to quantify hepatitis B virus DNA - Antiviral Medicine
Hepatitis C virus nonstructural 5A protein attenuates interferon-linked signals - More from this issue of Hepatitis Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
